Azo dye-induced alterations in vitamin B-6 metabolism and in pyridoxal 5'-phosphate-binding proteins in rat liver.
The effects of the hepatocarcinogen, 3'-methyl-4-dimethylamino-azobenzene, on vitamin B-6 metabolism in rat liver were studied. The following parameters were measured: pyridoxal 5'-phosphate (PLP) concentrations in plasma, brain, liver and azo dye-induced hepatomas, as well as the activities of pyridoxine (PN) kinase, pyridoxine 5'-phosphate (PNP) oxidase, PNP phosphatase and PLP-dependent ornithine decarboxylase. Hepatomas more closely resembled fetal than normal adult rat liver with respect to their ability to convert vitamer forms such as PN to coenzymatically active PLP. Microtiter plate enzyme-linked immunosorbent analyses revealed that the absence of PNP oxidase activity in a dissectable hepatoma was attributable to the absence of enzyme protein. In addition, monoclonal antibodies to vitamin B-6 were used in a Western immunoblot technique to examine the effects of azo dye ingestion on the pattern of PLP-binding proteins in cytosolic extracts of liver and hepatomas. Nitrocellulose blots of electrophoretically resolved cytosolic extracts probed for PLP-binding proteins showed increasing complexity with development; hepatomas bore a striking resemblance to fetal liver. The data indicate that hepatomas lose the properties of terminally differentiated hepatic tissue and take on the properties of fetal hepatic tissue characterized by lower concentrations of PLP, selective use of the coenzyme, and a lowered-to-absent capability to convert precursor vitamer forms to PLP. Therefore, with respect to vitamin B-6 metabolism and use, it appears likely that azo dye-induced hepatocarcinogenesis involves proliferation of a stem cell type(s) having the phenotypic characteristics of fetal hepatic tissue.
D000818:Animals; D003600:Cytosol / Q000201:enzymology; D003720:Densitometry; D004797:Enzyme-Linked Immunosorbent Assay; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism; D008297:Male; D008749:Methyldimethylaminoazobenzene / Q000494:pharmacology*; D009955:Ornithine Decarboxylase / Q000378:metabolism; D011731:Pyridoxal Kinase / Q000378:metabolism; D011732:Pyridoxal Phosphate / Q000097:blood / Q000378:metabolism; D011734:Pyridoxaminephosphate Oxidase / Q000378:metabolism; D011736:Pyridoxine / Q000097:blood*; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects*; D004124:p-Dimethylaminoazobenzene / Q000031:analogs & derivatives*
D011956:Receptors, Cell Surface; C037046:pyridoxal phosphate receptor; D008749:Methyldimethylaminoazobenzene; D011732:Pyridoxal Phosphate; D004124:p-Dimethylaminoazobenzene; D011734:Pyridoxaminephosphate Oxidase; D011731:Pyridoxal Kinase; D009955:Ornithine Decarboxylase; D011736:Pyridoxine